- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02060578
Determinants of End-of-life Place of Care for Children Suffering From Cancer. (DELI-DEVI)
DELI-DEVI : Determinants of End-of-life Place of Care for Children Suffering From Cancer.
Cancer is the second cause of over-one-year-old children mortality after accident. Survival rate is more than 70%, but in some cases, curative treatments are not sufficient and palliative support is implemented for those children in end of life.
Pediatric guidelines about the place of end-of-life care are varied. On European scale, home is recommended (IMPaCCT study, 2007). In France, the 2008-2012 palliative care development program recommended home or initial hospital care unit. This program also supports implementation of mobile team rather than specific hospital units.
In Brittany, a pattern of regional palliative care resource team has been implemented since 2005. In oncology, further to the guidelines, end-of-life place of care is often discussed several times for each case. Sometimes occur a lot of returns between home and hospital, psychological difficulties, and difficulties to offer adapted care conditions. Finally, less than 30% of children in palliative care decease at home.
The primary objective is to identify main determinants of the place of palliative care in pediatric oncology.
The secondary objective is to clarify the factors of change comparing to the initial planned place.
Intervention :
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Number of subjects is : Parents of 68 to 93 children who died from cancer after a palliative phase, that means 136 to 186 parents.
Expected results and perspectives :
Using both quantitative and qualitative methods, expected results are the followings:
- Identification of the objective and subjective factors, which influenced the decision of the place of care.
- Determination of the factors of change comparing to the initial planned place.
Once identified, main factors could be the ones to pay attention to in order to help for initial decision, better anticipation of change of place and better guidance of palliative care organization wherever, at home or in hospital.
Results would be new information for research on palliative care for children but also for adults.
Finally, this work is part of an improving approach of palliative care, related to the development of open-care hospital networks. We can expect some public health impacts with new arguments to help for complementary recommendations.
Study Overview
Detailed Description
Eligibility criteria :
Inclusion criteria are :
Parents of a deceased child
- From cancer, after palliative phase
- Age of death under 18 years old.
- Death occurred in Brittany
- Death between 2005 and 2010
Exclusion criterium is :
Parents of child who deceased after 2010 (respecting a bereavement delay)
Outcomes measures :
Primary study endpoint : Consideration or not by parents that they and/or their child had the choice of the end-of-life place of care.
Secondary study endpoints :
- objective factors : grade, occupational categories, marital status of parents, siblings, home conditions, access to the hospital, meeting with a professional of palliative care network, helpful general practitioner, volunteers, psychological support but also unexpected symptoms, needed nursing care which can explain a return from home to hospital for instance.
- subjective factors such as family or religious values, needs of intimacy, communication, support, sense of security, anxiety, fear, doubts about the next events.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Brittany
-
Rennes, Brittany, France, 35033
- Rennes University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Parents of a deceased child
- From cancer, after palliative phase
- Age of death under 18 years old.
- Death occurred in Brittany
- Death between 2005 and 2010
Exclusion Criteria:
Parents of child who deceased after 2010 (respecting a bereavement delay)
Study Plan
How is the study designed?
Design Details
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Intervention
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
|
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Consideration or not by parents that they and/or their child had the choice of the end-of-life place of care.
Time Frame: interview day
|
Consideration or not by parents that they and/or their child had the choice of the end-of-life place of care.
|
interview day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective factors
Time Frame: Interview day
|
Objective factors : grade, occupational categories, marital status of parents, siblings, home conditions, access to the hospital, meeting with a professional of palliative care network, helpful general practitioner, volunteers, psychological support but also unexpected symptoms, needed nursing care which can explain a return from home to hospital for instance
|
Interview day
|
|
Subjective factors
Time Frame: Interview day
|
Subjective factors such as family or religious values, needs of intimacy, communication, support, sense of security, anxiety, fear, doubts about the next events.
|
Interview day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Guillaume Robert, Rennes University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35RC13_9749_DELI-DEVI
- 13.04.08 (OTHER: CPP Ouest III (Poitiers))
- 13.428 (OTHER: CCTIRS)
- 913434 (OTHER: CNIL)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Questionnaire and interview
-
Northwestern UniversityRegeneron PharmaceuticalsCompletedPsoriasis | Atopic Dermatitis | IchthyosisUnited States
-
Institut de Cancérologie de la LoireCompleted
-
HaemnetBioMarin PharmaceuticalCompleted
-
Assistance Publique Hopitaux De MarseilleCompletedPsychology and CancerFrance
-
University Hospital, ToulouseCompletedParkinson Disease | COVIDFrance
-
National Taiwan UniversityMinistry of Science and Technology, TaiwanCompletedTransgender Persons | Sexual HealthTaiwan
-
Centre Hospitalier Universitaire DijonCompletedExpanded Newborn Screening | Parental AcceptabilityFrance
-
Imperial College LondonCompleted
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedHIV SeropositivityFrance
-
University Hospital, BordeauxRégion Nouvelle AquitaineCompletedObesity | Covid19France